Skip to main content
Top
Published in: AIDS and Behavior 4/2018

01-04-2018 | Original Paper

Strategies to Implement Pre-exposure Prophylaxis with Men Who Have Sex with Men in Ukraine

Authors: Alex Dubov, Liana Fraenkel, Roman Yorick, Adedotun Ogunbajo, Frederick L. Altice

Published in: AIDS and Behavior | Issue 4/2018

Login to get access

Abstract

Ukrainian men who have sex with men (MSM) remain highly stigmatized group with HIV prevalence as high as 23%. Despite documented effectiveness of pre-exposure prophylaxis (PrEP), PrEP remains unavailable in Ukraine. The aim of this study was to elicit MSM preferences in order to inform program development to facilitate successful delivery of PrEP to Ukrainian MSM. 1184 MSM were recruited through social networking applications to complete a stated preference (choice-based conjoint) survey. Respondents completed 14 choice tasks presenting experimentally-varied combinations of five attributes related to PrEP administration (dosing frequency, dispensing venue, prescription practices, adherence support, and costs). Latent class analysis was used to estimate the relative importance of each attribute and preferences across nine possible PrEP delivery programs. Preferences clustered into five groups. PrEP affordability was the most influential attribute across groups, followed by dosing strategy. Only one group preferred injectable PrEP (n = 216), while the other four groups disliked daily PrEP and strongly preferred the ‘on demand’ option. One group (n = 258) almost exclusively considered cost in their decision making. One group (n = 151) had very low level of interest in PrEP initiation correlated with low self-perceived risk for HIV. The two most at-risk groups (n = 415) were also more sensitive to changes in program delivery. PrEP uptake among MSM is most likely to be successful when PrEP is affordable, its implementation is targeted, provided as “on-demand” with associated education, and when more thorough medical care and related testing is provided to at-risk populations. Its introduction will need affirmation by the Ukrainian government, and guidelines that reflect safety, efficacy, and patient preferences.
Literature
4.
go back to reference Spindler H, Salyuk T, Vitek C, Rutherford G. Underreporting of HIV transmission among men who have sex with men in the Ukraine. AIDS Res Hum Retrovir. 2014;30(5):407–8.CrossRefPubMedPubMedCentral Spindler H, Salyuk T, Vitek C, Rutherford G. Underreporting of HIV transmission among men who have sex with men in the Ukraine. AIDS Res Hum Retrovir. 2014;30(5):407–8.CrossRefPubMedPubMedCentral
7.
go back to reference Bolshov YC, Kasyanczuk MG, Leschinskii YB, Trofimenko OV, Shvab IA. Monitoring of behavior and HIV prevalence among men having sex with men as a component of second generation HIV surveillance: analytical report on results of the linked survey of 2011. Kiev: ICF International HIV/AIDS Alliance in Ukraine; 2012 (in Ukrainian). Bolshov YC, Kasyanczuk MG, Leschinskii YB, Trofimenko OV, Shvab IA. Monitoring of behavior and HIV prevalence among men having sex with men as a component of second generation HIV surveillance: analytical report on results of the linked survey of 2011. Kiev: ICF International HIV/AIDS Alliance in Ukraine; 2012 (in Ukrainian).
8.
go back to reference Bolshov YS, Kasyanczuk MG, Leschinskii YB, Trofimenko OV, Shvab IA. Monitoring of behavior and HIV prevalence among men having sex with men as a component of second generation HIV surveillance: analytical report on results of the linked survey of 2009. Kiev: ICF International HIV/AIDS Alliance in Ukraine; 2011 (in Ukrainian). Bolshov YS, Kasyanczuk MG, Leschinskii YB, Trofimenko OV, Shvab IA. Monitoring of behavior and HIV prevalence among men having sex with men as a component of second generation HIV surveillance: analytical report on results of the linked survey of 2009. Kiev: ICF International HIV/AIDS Alliance in Ukraine; 2011 (in Ukrainian).
10.
go back to reference Bolshov YS, Kasianchuk MG, Leshchynskyi YB, Trofymenko LV, Shvab IA. Analytical report: behaviour monitoring and HIV-prevalence among men who have sex with men as a component of second generation surveillance. AIDS Alliance. 2012. Bolshov YS, Kasianchuk MG, Leshchynskyi YB, Trofymenko LV, Shvab IA. Analytical report: behaviour monitoring and HIV-prevalence among men who have sex with men as a component of second generation surveillance. AIDS Alliance. 2012.
11.
go back to reference Zhou F, Gao L, Li S, Li D, Zhang L, Fan W, Yang X, Yu M, Xiao D, Yan L, Zhang Z. Willingness to accept HIV pre-exposure prophylaxis among Chinese men who have sex with men. PLoS ONE. 2012;7(3):e32329.CrossRefPubMedPubMedCentral Zhou F, Gao L, Li S, Li D, Zhang L, Fan W, Yang X, Yu M, Xiao D, Yan L, Zhang Z. Willingness to accept HIV pre-exposure prophylaxis among Chinese men who have sex with men. PLoS ONE. 2012;7(3):e32329.CrossRefPubMedPubMedCentral
12.
go back to reference van Griensven F, Thienkrua W, Sukwicha W, Wimonsate W, Chaikummao S, Varangrat A, Mock PA. Sex frequency and sex planning among men who have sex with men in Bangkok, Thailand: implications for pre-and post-exposure prophylaxis against HIV infection. J Int AIDS Soc. 2010;13(1):13.CrossRefPubMedPubMedCentral van Griensven F, Thienkrua W, Sukwicha W, Wimonsate W, Chaikummao S, Varangrat A, Mock PA. Sex frequency and sex planning among men who have sex with men in Bangkok, Thailand: implications for pre-and post-exposure prophylaxis against HIV infection. J Int AIDS Soc. 2010;13(1):13.CrossRefPubMedPubMedCentral
13.
go back to reference Van der Elst EM, Mbogua J, Operario D, Mutua G, Kuo C, Mugo P, Kanungi J, Singh S, Haberer J, Priddy F, Sanders EJ. High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya. AIDS Behav. 2013;17(6):2162–72.CrossRefPubMedPubMedCentral Van der Elst EM, Mbogua J, Operario D, Mutua G, Kuo C, Mugo P, Kanungi J, Singh S, Haberer J, Priddy F, Sanders EJ. High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya. AIDS Behav. 2013;17(6):2162–72.CrossRefPubMedPubMedCentral
14.
go back to reference Poynten IM, Jin F, Prestage GP, Kaldor JM, Imrie J, Grulich AE. Attitudes towards new HIV biomedical prevention technologies among a cohort of HIV-negative gay men in Sydney, Australia. HIV Med. 2010;11(4):282–8.CrossRefPubMed Poynten IM, Jin F, Prestage GP, Kaldor JM, Imrie J, Grulich AE. Attitudes towards new HIV biomedical prevention technologies among a cohort of HIV-negative gay men in Sydney, Australia. HIV Med. 2010;11(4):282–8.CrossRefPubMed
15.
go back to reference Mutua G, Sanders E, Mugo P, Anzala O, Haberer JE, Bangsberg D, Barin B, Rooney JF, Mark D, Chetty P, Fast P. Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers. PLoS ONE. 2012;7(4):e33103.CrossRefPubMedPubMedCentral Mutua G, Sanders E, Mugo P, Anzala O, Haberer JE, Bangsberg D, Barin B, Rooney JF, Mark D, Chetty P, Fast P. Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers. PLoS ONE. 2012;7(4):e33103.CrossRefPubMedPubMedCentral
16.
go back to reference Lorente N, Fugon L, Carrieri MP, Andreo C, Le Gall JM, Cook E, Aboulker JP, Capitant C, Molina JM, Spire B. Acceptability of an “on-demand” pre-exposure HIV prophylaxis trial among men who have sex with men living in France. AIDS Care. 2012;24(4):468–77.CrossRefPubMed Lorente N, Fugon L, Carrieri MP, Andreo C, Le Gall JM, Cook E, Aboulker JP, Capitant C, Molina JM, Spire B. Acceptability of an “on-demand” pre-exposure HIV prophylaxis trial among men who have sex with men living in France. AIDS Care. 2012;24(4):468–77.CrossRefPubMed
17.
go back to reference Galea JT, Kinsler JJ, Salazar X, Lee SJ, Giron M, Sayles JN, Cáceres C, Cunningham WE. Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations. Int J STD AIDS. 2011;22(5):256–62.CrossRefPubMedPubMedCentral Galea JT, Kinsler JJ, Salazar X, Lee SJ, Giron M, Sayles JN, Cáceres C, Cunningham WE. Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations. Int J STD AIDS. 2011;22(5):256–62.CrossRefPubMedPubMedCentral
18.
go back to reference Eisingerich AB, Wheelock A, Gomez GB, Garnett GP, Dybul MR, Piot PK. Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study. PLoS ONE. 2012;7(1):e28238.CrossRefPubMedPubMedCentral Eisingerich AB, Wheelock A, Gomez GB, Garnett GP, Dybul MR, Piot PK. Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study. PLoS ONE. 2012;7(1):e28238.CrossRefPubMedPubMedCentral
19.
go back to reference Aghaizu A, Mercey D, Copas A, Johnson AM, Hart G, Nardone A. Who would use PrEP? Factors associated with intention to use among MSM in London: a community survey. Sex Transm Infect. 2013;89(3):207–11.CrossRefPubMed Aghaizu A, Mercey D, Copas A, Johnson AM, Hart G, Nardone A. Who would use PrEP? Factors associated with intention to use among MSM in London: a community survey. Sex Transm Infect. 2013;89(3):207–11.CrossRefPubMed
20.
go back to reference Hill PC, Pargament KI. Advances in the conceptualization and measurement of religion and spirituality: implications for physical and mental health research. Am Psychol. 2003;58(1):64–74.CrossRefPubMed Hill PC, Pargament KI. Advances in the conceptualization and measurement of religion and spirituality: implications for physical and mental health research. Am Psychol. 2003;58(1):64–74.CrossRefPubMed
21.
go back to reference Löwe B, Kroenke K, Gräfe K. Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res. 2005;58(2):163–71.CrossRefPubMed Löwe B, Kroenke K, Gräfe K. Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res. 2005;58(2):163–71.CrossRefPubMed
22.
go back to reference Li C, Friedman B, Conwell Y, Fiscella K. Validity of the Patient Health Questionnaire 2 (PHQ-2) in identifying major depression in older people. J Am Geriatr Soc. 2007;55(4):596–602.CrossRefPubMed Li C, Friedman B, Conwell Y, Fiscella K. Validity of the Patient Health Questionnaire 2 (PHQ-2) in identifying major depression in older people. J Am Geriatr Soc. 2007;55(4):596–602.CrossRefPubMed
24.
go back to reference Huber J, Orme B, Miller R. The value of choice simulators. In: Gustafsson A, Herrmann AF, editors. Conjoint measurement. 4th ed. New York: Springer; 2007. p. 347–62.CrossRef Huber J, Orme B, Miller R. The value of choice simulators. In: Gustafsson A, Herrmann AF, editors. Conjoint measurement. 4th ed. New York: Springer; 2007. p. 347–62.CrossRef
25.
go back to reference Orme B. Market simulators for conjoint analysis. Getting started with conjoint analysis: strategies for product design and pricing research. 2nd ed. Madison: Research Publishers LLC; 2010. Orme B. Market simulators for conjoint analysis. Getting started with conjoint analysis: strategies for product design and pricing research. 2nd ed. Madison: Research Publishers LLC; 2010.
26.
go back to reference Huber J, Orme B, Miller R. The value of choice simulators. In: Gustafsson A, Herrmann AF, editors. Conjoint measurement. 4th ed. New York: Springer; 2007. p. 347–62.CrossRef Huber J, Orme B, Miller R. The value of choice simulators. In: Gustafsson A, Herrmann AF, editors. Conjoint measurement. 4th ed. New York: Springer; 2007. p. 347–62.CrossRef
28.
go back to reference World Health Organization. Policy brief: pre-exposure prophylaxis (PrEP): WHO expands recommendation on oral pre-exposure prophylaxis of HIV infection (PrEP). Geneva: World Health Organization; 2015. World Health Organization. Policy brief: pre-exposure prophylaxis (PrEP): WHO expands recommendation on oral pre-exposure prophylaxis of HIV infection (PrEP). Geneva: World Health Organization; 2015.
29.
go back to reference Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, Tremblay C, Le Gall JM, Cua E, Pasquet A, Raffi F. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237–46.CrossRefPubMed Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, Tremblay C, Le Gall JM, Cua E, Pasquet A, Raffi F. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237–46.CrossRefPubMed
30.
go back to reference Charpentier N, Quatremère G, Mabire X, Roduit S, Laguette V, Spittler D, Guillois E, Martin C, Castro DR, Préau M. Freins et leviers de la prise en charge du traitement post-exposition au VIH. Santé Publique. 2016;28(6):791–9.CrossRefPubMed Charpentier N, Quatremère G, Mabire X, Roduit S, Laguette V, Spittler D, Guillois E, Martin C, Castro DR, Préau M. Freins et leviers de la prise en charge du traitement post-exposition au VIH. Santé Publique. 2016;28(6):791–9.CrossRefPubMed
31.
go back to reference Ryom L, Boesecke C, Gisler V, Manzardo C, Rockstroh JK, Puoti M, Furrer H, Miro JM, Gatell JM, Pozniak A, Behrens G. Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons. HIV Med. 2016;17(2):83–8.CrossRefPubMed Ryom L, Boesecke C, Gisler V, Manzardo C, Rockstroh JK, Puoti M, Furrer H, Miro JM, Gatell JM, Pozniak A, Behrens G. Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons. HIV Med. 2016;17(2):83–8.CrossRefPubMed
32.
go back to reference Eisingerich AB, Wheelock A, Gomez GB, Garnett GP, Dybul MR, Piot PK. Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study. PLoS ONE. 2012;7(1):e2823.CrossRef Eisingerich AB, Wheelock A, Gomez GB, Garnett GP, Dybul MR, Piot PK. Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study. PLoS ONE. 2012;7(1):e2823.CrossRef
33.
go back to reference Castro DR, Quatremere G, Sagaon-Teyssier L, Le Gall JM, Preau M, Suzan-Monti M, Spire B. Informal pre-exposure prophylaxis use in France: results from the Flash Prep survey (2014). HIV Med. 2017;18(4):308–10.CrossRef Castro DR, Quatremere G, Sagaon-Teyssier L, Le Gall JM, Preau M, Suzan-Monti M, Spire B. Informal pre-exposure prophylaxis use in France: results from the Flash Prep survey (2014). HIV Med. 2017;18(4):308–10.CrossRef
34.
go back to reference Dubov A, Ogunbajo A, Yorik R, Altice F, Fraenkel L. Knowledge, beliefs, and willingness to prescribe PrEP among infectious disease providers in Ukraine. J Assoc Nurses AIDS Care (forthcoming). Dubov A, Ogunbajo A, Yorik R, Altice F, Fraenkel L. Knowledge, beliefs, and willingness to prescribe PrEP among infectious disease providers in Ukraine. J Assoc Nurses AIDS Care (forthcoming).
35.
go back to reference Dubov A, Ogunbajo A, Altice, F, Fraenkel L. Optimizing access to PrEP based on MSM preferences: results of a discreet choice experiment. HIV Med (forthcoming). Dubov A, Ogunbajo A, Altice, F, Fraenkel L. Optimizing access to PrEP based on MSM preferences: results of a discreet choice experiment. HIV Med (forthcoming).
Metadata
Title
Strategies to Implement Pre-exposure Prophylaxis with Men Who Have Sex with Men in Ukraine
Authors
Alex Dubov
Liana Fraenkel
Roman Yorick
Adedotun Ogunbajo
Frederick L. Altice
Publication date
01-04-2018
Publisher
Springer US
Published in
AIDS and Behavior / Issue 4/2018
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-017-1996-y

Other articles of this Issue 4/2018

AIDS and Behavior 4/2018 Go to the issue